SGLT-2 inhibitors in diabetic kidney disease : what lies behind their renoprotective properties?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Current medicinal chemistry - 26(2019), 29, Seite 5564-5578 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Georgianos, Panagiotis I. [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.2174/0929867325666180524114033 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1045078492 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | 1045078492 | ||
| 003 | DE-627 | ||
| 005 | 20230427192742.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181228s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/0929867325666180524114033 |2 doi | |
| 035 | |a (DE-627)1045078492 | ||
| 035 | |a (DE-599)GBV1045078492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Georgianos, Panagiotis I. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SGLT-2 inhibitors in diabetic kidney disease |b what lies behind their renoprotective properties? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Divani, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Eleftheriadis, Theodoros |e verfasserin |4 aut | |
| 700 | 1 | |a Mertens, Peter Rene |d 1964- |e verfasserin |0 (DE-588)123216877 |0 (DE-627)082418772 |0 (DE-576)293609233 |4 aut | |
| 700 | 1 | |a Liakopoulos, Vassilios |e verfasserin |0 (DE-588)116519449X |0 (DE-627)1029355339 |0 (DE-576)510305830 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 1996 |g 26(2019), 29, Seite 5564-5578 |h Online-Ressource |w (DE-627)325051623 |w (DE-600)2034240-8 |w (DE-576)273880209 |x 1875-533X |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2019 |g number:29 |g pages:5564-5578 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/0929867325666180524114033 |x Resolving-System |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_178 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_1200 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 936 | u | w | |d 26 |j 2019 |e 29 |h 5564-5578 |
| 951 | |a AR | ||
| 952 | |d 26 |j 2019 |e 29 |h 5564-5578 | ||
| 980 | |2 178 |1 01 |x 3178 |b 183724054X |y x |z 28-12-18 | ||
| 982 | |2 178 |1 00 |x 3178 |8 00 |0 (DE-627)504384899 |a Universitätsklinik für Nieren- und Hochdruckkrankheiten, Diabetologie und Endokrinologie <Magdeburg> | ||
| 982 | |2 178 |1 00 |x 3178 |8 01 |a Mertens, Peter R. / KNEP | ||
| 982 | |2 178 |1 00 |x 3178 |8 02 |0 (DE-627)719906830 |a begutachteter Zeitschriftenartikel (peer reviewed) | ||
| 983 | |2 178 |1 00 |x 3178 |8 00 |a Impact factor: 3.894 | ||
| 983 | |2 178 |1 01 |x 3178 |8 99 |a j2019 | ||